EA200970893A1 - Профилактическое средство против сердечной недостаточности - Google Patents

Профилактическое средство против сердечной недостаточности

Info

Publication number
EA200970893A1
EA200970893A1 EA200970893A EA200970893A EA200970893A1 EA 200970893 A1 EA200970893 A1 EA 200970893A1 EA 200970893 A EA200970893 A EA 200970893A EA 200970893 A EA200970893 A EA 200970893A EA 200970893 A1 EA200970893 A1 EA 200970893A1
Authority
EA
Eurasian Patent Office
Prior art keywords
heart failure
means against
against heart
preventive means
agent
Prior art date
Application number
EA200970893A
Other languages
English (en)
Other versions
EA016808B1 (ru
Inventor
Тацухико Хирота
Кохдзи Охки
Теппеи Накамура
Тосиаки Такано
Original Assignee
Калпис Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Калпис Ко., Лтд. filed Critical Калпис Ко., Лтд.
Publication of EA200970893A1 publication Critical patent/EA200970893A1/ru
Publication of EA016808B1 publication Critical patent/EA016808B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Настоящее изобретение относится к средству, обладающему супрессивным действием в отношении утолщения стенки сердца, профилактическому средству против сердечной недостаточности, содержащему описанное выше средство, и продуктам функционального питания, которые, как полагают, должны обладать профилактическим эффектом против сердечной недостаточности. Средство для супрессии утолщения стенки сердца содержит в качестве действующего вещества Хаа Pro Pro.
EA200970893A 2007-03-27 2008-03-19 ПРИМЕНЕНИЕ ТРИПЕПТИДОВ Val Pro Pro И Ile Pro Pro ДЛЯ СУПРЕССИИ УТОЛЩЕНИЯ СТЕНКИ СЕРДЦА EA016808B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007081638 2007-03-27
PCT/JP2008/055072 WO2008123095A1 (ja) 2007-03-27 2008-03-19 心不全予防剤

Publications (2)

Publication Number Publication Date
EA200970893A1 true EA200970893A1 (ru) 2010-04-30
EA016808B1 EA016808B1 (ru) 2012-07-30

Family

ID=39830596

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200970893A EA016808B1 (ru) 2007-03-27 2008-03-19 ПРИМЕНЕНИЕ ТРИПЕПТИДОВ Val Pro Pro И Ile Pro Pro ДЛЯ СУПРЕССИИ УТОЛЩЕНИЯ СТЕНКИ СЕРДЦА

Country Status (10)

Country Link
US (4) US20100022747A1 (ru)
EP (2) EP2130546B1 (ru)
JP (2) JP5292633B2 (ru)
KR (2) KR20090127174A (ru)
CN (2) CN101678071A (ru)
BR (1) BRPI0809319A2 (ru)
CA (2) CA2681746C (ru)
EA (1) EA016808B1 (ru)
MX (2) MX2009010427A (ru)
WO (2) WO2008123095A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090127174A (ko) 2007-03-27 2009-12-09 칼피스가부시키가이샤 심부전 예방제
JP5686680B2 (ja) * 2011-06-24 2015-03-18 カルピス株式会社 乳酸菌発酵によるカゼイン由来ペプチドの製造方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2782142B2 (ja) * 1992-07-23 1998-07-30 カルピス株式会社 アンジオテンシン変換酵素阻害剤及びその製造法
JP3028411B2 (ja) * 1997-09-26 2000-04-04 カルピス株式会社 トリペプチド高生産性ラクトバチルス・ヘルベチカス乳酸菌
FI113741B (fi) * 1999-11-01 2004-06-15 Valio Oy Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi
US7785824B2 (en) 2003-05-05 2010-08-31 Conopco Inc. Hydrolysed casein product comprising tripeptides IPP and/or VPP
KR101174299B1 (ko) * 2003-08-01 2012-08-16 칼피스가부시키가이샤 카세인 가수분해물, 그 제조법 및 그 용도
JP2008505653A (ja) * 2004-07-12 2008-02-28 ディーエスエム アイピー アセッツ ビー．ブイ． 血圧降下タンパク質加水分解物
JP2008515903A (ja) * 2004-10-08 2008-05-15 ノバルティス アクチエンゲゼルシャフト 拡張機能障害または拡張期心不全の予防または処置のためのレニン阻害剤の使用
US20060205642A1 (en) * 2005-03-08 2006-09-14 Vesely David L Oral methods of treatment using proANF peptides
CN101272693B (zh) * 2005-07-26 2012-08-01 卡尔皮斯株式会社 发酵乳的制造方法和发酵乳饮料食品
EP1992354B1 (en) * 2006-02-09 2014-04-09 Calpis Co., Ltd. Rheumatoid arthritis-preventive agent for oral intake
US20090299036A1 (en) * 2006-02-14 2009-12-03 Calpis Co, Ltd Agent for preventing arteriosclerosis, agent for suppressing vascular intimal thickening and agent for improving vascular endothelial function
EA200870259A1 (ru) * 2006-02-14 2009-02-27 Калпис Ко., Лтд. Сосудорасширяющее средство
KR20090127174A (ko) * 2007-03-27 2009-12-09 칼피스가부시키가이샤 심부전 예방제

Also Published As

Publication number Publication date
CA2681551A1 (en) 2008-10-16
MX2009010427A (es) 2009-10-20
CA2681746C (en) 2014-04-29
US20100022747A1 (en) 2010-01-28
JP5292632B2 (ja) 2013-09-18
US20120077735A1 (en) 2012-03-29
EP2138184A1 (en) 2009-12-30
CN101678071A (zh) 2010-03-24
CA2681551C (en) 2014-06-10
US20100022748A1 (en) 2010-01-28
US8673854B2 (en) 2014-03-18
EP2130546A4 (en) 2010-03-31
KR20090127174A (ko) 2009-12-09
EP2138184A4 (en) 2010-04-07
JPWO2008123095A1 (ja) 2010-07-15
EA016808B1 (ru) 2012-07-30
KR20090130303A (ko) 2009-12-22
EP2138184B1 (en) 2013-09-18
BRPI0809319A2 (pt) 2014-09-23
CA2681746A1 (en) 2008-10-16
EP2130546B1 (en) 2013-02-27
JP5292633B2 (ja) 2013-09-18
US20120058947A1 (en) 2012-03-08
JPWO2008123096A1 (ja) 2010-07-15
WO2008123095A1 (ja) 2008-10-16
WO2008123096A1 (ja) 2008-10-16
CN101641113A (zh) 2010-02-03
EP2130546A1 (en) 2009-12-09
MX2009010428A (es) 2009-12-01

Similar Documents

Publication Publication Date Title
EA201190144A1 (ru) Изотиазолилоксифениламидины и их применение в качестве фунгицидов
CL2014000270A1 (es) Compuestos derivados de 3,5-difenil diazoles sustituidos, inhibidores de la agregacion de proteinas. (divisional de la solicitud n° 1369-2010).
EA201791744A3 (ru) Улучшенная липидная композиция
CL2012003226A1 (es) Compuestos derivados de 5-fluoro-1h-pirazolopiridina ; procedimiento de preparacion de estos; composicion framaceutica que los comprende; y su uso en el tratamiento de enfermedades cardiovasculares, sexuales y metabolicas.
TN2012000451A1 (en) Clay compositions
BR112015023434A2 (pt) inibidores de histona deacetilase
MY178905A (en) Prevention, treatment and diagnosis of p.gingivalis infection
MX2011014019A (es) Derivados de diazahomoadamantano y sus metodos de uso.
EA201490688A1 (ru) 2-тиопиримидиноны
MX2013000191A (es) Combinaciones de compuestos activos.
EA201270256A1 (ru) Производные т1-замещенного 5-фтор-2-оксопиримидинон-1 (2h) -карбоксамида
WO2011161396A3 (en) Disinfectant composition
WO2012104240A3 (de) Kosmetische verwendung
EA201070967A1 (ru) Улучшенные ароматизированные кондитерские продукты
MX2010012638A (es) Solucion acuosa para la preservacion de tejidos y organos.
WO2009040314A3 (de) Neue heteroarylsubstituierte acetonderivate, geeignet zur hemmung der phospholipase a2
MY161419A (en) Skin collagen production-promoting agent
UA103996C2 (en) Ivabradine hydrobromide
MX2013013828A (es) Una composicion para la preparacion de acido hialuronico reticulado viscoelastico, y acido hialuronico reticulado obtenido al usar la misma.
CO6761388A2 (es) Composiciones pharmaceuticas que comprenden alisporivir
BR112014032125A2 (pt) bebida que contém extrato de meio aquoso de lúpulo submetido ao tratamento de oxidação
EA200970893A1 (ru) Профилактическое средство против сердечной недостаточности
WO2011140334A3 (en) Compounds, methods of making or identifying compounds, and uses thereof
CL2007002037A1 (es) Compuesto derivado de azolopirimidinas; procedimiento para la preparacion de dichos compuestos; compuestos intermediarios; producto; semillas; y procedimiento para combatir hongos nocivos fitopatogenos.
GB2501427A (en) A washing capsule for providing washing compositions to a machine

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU